Raymond R. Tubbs
#135,936
Most Influential Person Now
Raymond R. Tubbs's AcademicInfluence.com Rankings
Raymond R. Tubbsmedical Degrees
Medical
#2357
World Rank
#2777
Historical Rank
Oncology
#139
World Rank
#144
Historical Rank
Raymond R. Tubbsbiology Degrees
Biology
#9322
World Rank
#12511
Historical Rank
Pathology
#123
World Rank
#240
Historical Rank
Download Badge
Medical Biology
Why Is Raymond R. Tubbs Influential?
(Suggest an Edit or Addition)Raymond R. Tubbs's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. (2006) (3857)
- Stromal gene signatures in large-B-cell lymphomas. (2008) (1611)
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma (2010) (1436)
- American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. (2007) (1419)
- Oncogenically active MYD88 mutations in human lymphoma (2011) (1341)
- Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. (2010) (1140)
- Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. (2012) (844)
- Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics (2012) (766)
- T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. (1988) (688)
- Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant (2006) (589)
- Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. (2014) (510)
- Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. (1993) (432)
- Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. (2012) (386)
- Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message. (2001) (368)
- The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. (1998) (305)
- Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. (2003) (284)
- Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma. (2013) (283)
- Long-term follow-up after partial removal of a solitary kidney. (1991) (275)
- Breast Cancers With Brain Metastases are More Likely to be Estrogen Receptor Negative, Express the Basal Cytokeratin CK5/6, and Overexpress HER2 or EGFR (2006) (267)
- Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms (2008) (232)
- Uniform detection of immunoglobulin-gene rearrangement in benign lymphoepithelial lesions. (1987) (229)
- Loss of signaling via Gα13 in germinal center B cell-derived lymphoma (2014) (226)
- Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines. (2009) (223)
- The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. (2005) (189)
- Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. (1996) (183)
- Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings. (2007) (182)
- T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. (1993) (177)
- BRAF-mutated, Microsatellite-stable Adenocarcinoma of the Proximal Colon: An Aggressive Adenocarcinoma With Poor Survival, Mucinous Differentiation, and Adverse Morphologic Features (2012) (174)
- Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelines. (2005) (171)
- BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab (2011) (170)
- The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. (2000) (162)
- Mechanisms of apoptosis in T cells from patients with renal cell carcinoma. (1999) (158)
- High false-negative rate of HER2 quantitative reverse transcription polymerase chain reaction of the Oncotype DX test: an independent quality assurance study. (2011) (157)
- Enzyme immunohistochemistry: technical aspects. (1984) (154)
- An International Interpretation Study Using the ALK IHC Antibody D5F3 and a Sensitive Detection Kit Demonstrates High Concordance between ALK IHC and ALK FISH and between Evaluators (2014) (152)
- The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy (2009) (151)
- Light chain nephropathy. (1981) (147)
- Tissue Microarrays: A Powerful Tool for High-Throughput Analysis of Clinical Specimens: A Review of the Method With Validation Data (2002) (137)
- Prospective Evaluation of TLE1 as a Diagnostic Immunohistochemical Marker in Synovial Sarcoma (2009) (137)
- Systemic vasculitis in association with human immunodeficiency virus infection. (1989) (131)
- HER2/neu amplification in breast cancer: stratification by tumor type and grade. (2002) (131)
- Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms. (2014) (125)
- Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities. (2011) (124)
- The Influence of Polysomy 17 on HER2 Gene and Protein Expression in Adenocarcinoma of the Breast: A Fluorescent In Situ Hybridization, Immunohistochemical, and Isotopic mRNA In Situ Hybridization Study (2005) (123)
- ALK status testing in non-small cell lung carcinoma: correlation between ultrasensitive IHC and FISH. (2013) (119)
- Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP. (2013) (117)
- Renal Tubulocystic Carcinoma Is Closely Related to Papillary Renal Cell Carcinoma: Implications for Pathologic Classification (2009) (116)
- Clinical laboratory reports in molecular pathology. (2007) (115)
- High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy (2011) (111)
- Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma. (2015) (110)
- The Utility of Fluorescence In Situ Hybridization (FISH) in the Diagnosis of Myxoid Soft Tissue Neoplasms (2008) (109)
- Dual-color, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma (2005) (109)
- The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features. (2001) (108)
- Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization. (2000) (107)
- Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH) (2008) (106)
- Characterization of a human renal cell carcinoma specific cytotoxic CD8+ T cell line. (1992) (106)
- FISH for MYC amplification and anti‐MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations (2012) (106)
- Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma. (1991) (106)
- Angiotropic Lymphoma: An Immunophenotypically and Clinically Heterogeneous Lymphoma (2001) (104)
- Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma. (1990) (102)
- Autoimmune oophoritis: a histopathologic study of involved ovaries with immunologic characterization of the mononuclear cell infiltrate. (1987) (102)
- Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis. (2012) (101)
- Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation. (1983) (101)
- Antikeratin antibodies in tumor diagnosis. Distinction between seminoma and embryonal carcinoma (1984) (101)
- Ki‐67‐determined growth fraction versus standard staging and grading parameters in colorectal carcinoma: A multivariate analysis (1992) (100)
- Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose well-differentiated liposarcoma? (2010) (99)
- Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease. (2014) (98)
- p53 overexpression is Not an independent prognostic factor for patients with primary ovarian epithelial cancer (1997) (96)
- Sensitive in situ hybridization with catalyzed reporter deposition, streptavidin-Nanogold, and silver acetate autometallography: detection of single-copy human papillomavirus. (1997) (95)
- Loss of Breast Cancer Metastasis Suppressor 1 Protein Expression Predicts Reduced Disease-Free Survival in Subsets of Breast Cancer Patients (2006) (94)
- Small noncleaved B cell Burkitt-like lymphoma with chromosome t(8;14) translocation and Epstein-Barr virus nuclear-associated antigen in a homosexual man with acquired immune deficiency syndrome. (1985) (94)
- HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization (2011) (93)
- Squamous cell carcinoma of the nail bed: a clinicopathological study of 12 cases (1990) (92)
- Silver In Situ Hybridization (SISH) For Determination of HER2 Gene Status in Breast Carcinoma: Comparison With FISH and Assessment of Interobserver Reproducibility (2010) (91)
- Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma (2010) (90)
- T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappa B-specific DNA-binding activity: a preliminary report. (1994) (90)
- Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas. (1997) (90)
- WAVE3, an actin remodeling protein, is regulated by the metastasis suppressor microRNA, miR‐31, during the invasion‐metastasis cascade (2011) (89)
- A prospective comparison of DNA quantitation by image and flow cytometry. (1990) (88)
- Immunohistology of lymphoproliferative disorders. (1984) (85)
- Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis. (2001) (84)
- T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present. (1995) (83)
- Membranous glomerulonephritis associated with industrial mercury exposure. Study of pathogenetic mechanisms. (1982) (82)
- Definitive role of CT scanning of the pancreas. The second year's experience. (1977) (82)
- Angiotensin II receptor subtypes in the human renal cortex and renal cell carcinoma. (1994) (81)
- Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray. (2001) (81)
- Extranodal Marginal Zone B-cell Lymphomas of the Ocular Adnexa: Multiparameter Analysis of 34 Cases Including Interphase Molecular Cytogenetics and PCR for Chlamydia psittaci (2007) (80)
- Identification of the JAK2 V617F mutation in chronic myeloproliferative disorders using FRET probes and melting curve analysis. (2006) (80)
- Infectious crystalline keratopathy. (1984) (80)
- Fluorescence In Situ Hybridization (FISH) as Primary Methodology for the Assessment of HER2 Status in Adenocarcinoma of the Breast: A Single Institution Experience (2007) (80)
- Renal oncocytoma: clinical and biological correlates. (1993) (79)
- Characterization of tumor-infiltrating lymphocyte subsets from human renal cell carcinoma: specific reactivity defined by cytotoxicity, interferon-gamma secretion, and proliferation. (1994) (79)
- Pulmonary vasculitis (Wegener's granulomatosis). Immunohistochemical study of T and B cell markers. (1983) (79)
- Human intestinal mucosal mononuclear cells exhibit lymphokine-activated killer cell activity. (1985) (78)
- Prostate Cancer in African American Men Is Associated With Downregulation of Zinc Transporters (2003) (77)
- Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E2 and other cyclic adenosine monophosphate-elevating agents: impact on interleukin-2 receptor signaling pathway. (1999) (76)
- Delay to formalin fixation ‘cold ischemia time’: effect on ERBB2 detection by in-situ hybridization and immunohistochemistry (2013) (76)
- U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations. (1997) (75)
- Desquamative interstitial pneumonitis. Cellular phase of fibrosing alveolitis. (1977) (73)
- HER2 overexpression and amplification in urothelial carcinoma of the bladder is associated with MYC coamplification in a subset of cases. (2008) (73)
- Accurate Classification of Diffuse Large B-Cell Lymphoma into Germinal Center and Activated B-Cell Subtypes Using a Nuclease Protection Assay on Formalin-Fixed, Paraffin-Embedded Tissues (2011) (73)
- Therapeutic response of breast carcinoma monitored by 31P MRS in situ (1989) (73)
- Utility of FISH in the diagnosis of angiomatoid fibrous histiocytoma: a series of 18 cases (2010) (69)
- Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status. (2009) (69)
- A New Rabbit Monoclonal Antibody (4B5) for the Immunohistochemical (IHC) Determination of the HER2 Status in Breast Cancer: Comparison With CB11, Fluorescence In Situ Hybridization (FISH), and Interlaboratory Reproducibility (2007) (65)
- Detection of MDM2 gene amplification or protein expression distinguishes sclerosing mesenteritis and retroperitoneal fibrosis from inflammatory well-differentiated liposarcoma (2009) (64)
- Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease. (1992) (64)
- Intracranial extension of inflammatory pseudotumor of the orbit. Case report. (1984) (63)
- HER-2 testing in breast cancer. (2004) (63)
- The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: a fluorescence in situ hybridization study. (2005) (63)
- A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma. (2012) (62)
- Malignant angioendotheliomatosis: an angiotropic lymphoma. (1989) (62)
- Human neoplasm pH and response to radiation therapy: P-31 MR spectroscopy studies in situ. (1989) (62)
- Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimens (2004) (62)
- Phase I Clinical Trial of Interleukin 2 and α-Interferon: Toxicity and Immunologic Effects (1989) (62)
- Impaired Activation of NFκB in T Cells From a Subset of Renal Cell Carcinoma Patients Is Mediated by Inhibition of Phosphorylation and Degradation of the Inhibitor, IκB (1998) (61)
- Variation of monosomy 3 status within uveal melanoma. (2007) (61)
- Posttransplant Lymphoproliferative Disorders in Lung Transplant Patients: The Cleveland Clinic Experience (2002) (60)
- Identification of monoclonal B-cell populations by rapid cycle polymerase chain reaction. A practical screening method for the detection of immunoglobulin gene rearrangements. (1992) (60)
- Determination of bone mineral content using CT scanning. (1976) (59)
- Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically. (2001) (57)
- An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR. (2007) (57)
- Automated quantitative RNA in situ hybridization for resolution of equivocal and heterogeneous ERBB2 (HER2) status in invasive breast carcinoma. (2013) (56)
- Tumor‐Infiltrating Lymphocytes in Patients with Renal‐Cell Carcinoma (1988) (55)
- Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease (1992) (54)
- ALK Status Testing in Non–Small-Cell Lung Carcinoma by FISH on ThinPrep Slides with Cytology Material (2014) (53)
- p53 immunoreactivity in Barrett's metaplasia, dysplasia, and carcinoma. (1994) (52)
- Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers (2001) (51)
- Randomized phase III U.S./Canadian intergroup trial (SWOG S9704) comparing CHOP ± R for eight cycles to CHOP ± R for six cycles followed by autotransplant for patients with high-intermediate (H-Int) or high IPI grade diffuse aggressive non-Hodgkin lymphoma (NHL). (2011) (51)
- G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer (2012) (51)
- Immunohistochemical analysis identifies two cyclin D1+ subsets of plasma cell myeloma, each associated with favorable survival. (2006) (51)
- Gold-facilitated in situ hybridization: a bright-field autometallographic alternative to fluorescence in situ hybridization for detection of Her-2/neu gene amplification. (2002) (51)
- Clinical Significance of MYC Expression and/or “High-grade” Morphology in Non-Burkitt, Diffuse Aggressive B-cell Lymphomas: A SWOG S9704 Correlative Study (2014) (50)
- Post-transplantation reticulum-cell sarcoma reclassified as B-cell lymphoma. (1985) (50)
- Solitary primary lymphoma of the sciatic nerve: case report. (1988) (50)
- Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study. (2010) (49)
- Flow cytometric immunophenotyping of non-Hodgkin's lymphomas and related disorders. (1996) (49)
- Utilization of fluorescence in situ hybridization in the diagnosis of 230 mesenchymal neoplasms: an institutional experience. (2010) (48)
- Solitary fibrous tumor: is there a molecular relationship with cellular angiofibroma, spindle cell lipoma, and mammary-type myofibroblastoma? (2012) (48)
- Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinoma (2010) (48)
- Evaluation of a new paraffin-reactive CD7 T-cell deletion marker and a polymerase chain reaction-based T-cell receptor gene rearrangement assay: implications for diagnosis of mycosis fungoides in community clinical practice. (2001) (48)
- The pulmonary manifestations of systemic lupus erythematosus. (1985) (47)
- EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC). (2014) (47)
- Bone Marrow Phospho-STAT5 Expression in Non-CML Chronic Myeloproliferative Disorders Correlates With JAK2 V617F Mutation and Provides Evidence of In Vivo JAK2 Activation (2007) (47)
- The impact of genotype on outcome in oligodendroglioma: validation of the loss of chromosome arm 1p as an important factor in clinical decision making. (2006) (46)
- Diagnostic yield of bone marrow and peripheral blood FISH panel testing in clinically suspected myelodysplastic syndromes and/or acute myeloid leukemia: a prospective analysis of 433 cases. (2011) (46)
- Rheumatoid arthritis complicated by infection with the human immunodeficiency virus and the development of Sjögren's syndrome. (1989) (46)
- Analytical Validation and Interobserver Reproducibility of EnzMet GenePro: A Second-Generation Bright-Field Metallography Assay for Concomitant Detection of HER2 Gene Status and Protein Expression in Invasive Carcinoma of the Breast (2005) (46)
- Interferon-γ and CXC Chemokine Induction by Interleukin 12 in Renal Cell Carcinoma (1999) (45)
- Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer (2012) (45)
- HER-2 fluorescence in situ hybridization: results from the survey program of the College of American Pathologists. (2006) (44)
- Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with interferon-alpha and interleukin-2. (1994) (43)
- L3T4 (CD4+) cells that mediate contact sensitivity to trinitrochlorobenzene express I-A determinants. (1991) (42)
- Perforating granuloma annulare in a patient with acquired immunodeficiency syndrome. Immunohistologic evaluation of the cellular infiltrate. (1987) (42)
- Validation of a multicolor interphase fluorescence in situ hybridization assay for detection of transitional cell carcinoma on fresh and archival thin-layer, liquid-based cytology slides. (2001) (42)
- HER2 testing: a review of detection methodologies and their clinical performance (2007) (42)
- The Expression of the Cytoskeletal Focal Adhesion Protein Paxillin in Breast Cancer Correlates with HER2 Overexpression and May Help Predict Response to Chemotherapy: A Retrospective Immunohistochemical Study (2007) (42)
- Til from renal‐cell carcinoma: Restimulation with tumor influences proliferation and cytolytic activity (1990) (41)
- Immunohistochemistry of Warthin's tumor. (1980) (41)
- The influence of cytokines on the adhesion of renal cancer cells to endothelium. (1996) (41)
- Interlaboratory comparison of immunohistochemical testing for HER2: results of the 2004 and 2005 College of American Pathologists HER2 Immunohistochemistry Tissue Microarray Survey. (2009) (40)
- The expanded histologic spectrum of myxoid liposarcoma with an emphasis on newly described patterns: implications for diagnosis on small biopsy specimens. (2012) (40)
- Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: clinical results and immunologic correlates of response. (1997) (39)
- Interactive effects of alpha-interferon A/D and interleukin 2 on murine lymphokine-activated killer activity: analysis at the effector and precursor level. (1990) (38)
- Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancer (2010) (37)
- Automated Colorimetric In Situ Hybridization (CISH) Detection of Immunoglobulin (Ig) Light Chain mRNA Expression in Plasma Cell (PC) Dyscrasias and Non-Hodgkin Lymphoma (2003) (37)
- p53 and HER-2/neu overexpression in ovarian borderline tumors. (1997) (36)
- Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism array. (2012) (36)
- Circulating tumor cells in uveal melanoma. (2011) (36)
- Chronic glomerular microangiopathy and metastatic carcinoma. (1979) (36)
- Intercellular adhesion molecule-1 expression by bladder cancer cells: functional effects. (1994) (36)
- Characterization of two cell lines with distinct phenotypes and genotypes established from a patient with renal cell carcinoma. (1989) (35)
- Tissue immunomicroscopic evaluation of monoclonality of B-cell lymphomas: comparison with cell suspension studies. (1981) (35)
- Gamma Heavy-chain Disease: Defining the Spectrum of Associated Lymphoproliferative Disorders Through Analysis of 13 Cases (2012) (35)
- t(14;18)(q32;q21) involving IGH and MALT1 is uncommon in cutaneous MALT lymphomas and primary cutaneous diffuse large B‐cell lymphomas (2006) (34)
- Posterior midventricular rupture after mitral valve replacement. (1979) (34)
- The effect of fixation on detection of B-cell clonality by polymerase chain reaction. (1999) (34)
- Membranous glomerulopathy associated with captopril therapy. (1983) (34)
- Chromosome 1p allelic loss by fluorescence in situ hybridization is not observed in dysembryoplastic neuroepithelial tumors. (2002) (34)
- Role of HPV DNA testing in predicting cervical intraepithelial lesions: Comparison of HC HPV and ISH HPV (2003) (34)
- Precursor langerhans cell histiocytosis (1992) (33)
- Cell and tissue based molecular pathology (2009) (33)
- Immunohistochemistry of fresh-frozen lymphoid tissue with the direct immunoperoxidase technic. (1981) (33)
- Metallographic in situ hybridization. (2007) (33)
- The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence (2010) (33)
- The "CD43 only" phenotype. An aberrant, nonspecific immunophenotype requiring comprehensive analysis for lineage resolution. (1992) (33)
- FUS (16p11) Gene Rearrangement as Detected by Fluorescence In-Situ Hybridization in Cutaneous Low-Grade Fibromyxoid Sarcoma: A Potential Diagnostic Tool (2011) (33)
- Microsatellite instability at a single locus (D11S988) on chromosome 11p15.5 as a late event in mammary tumorigenesis. (1995) (32)
- Fluorescence in situ hybridization of cytologic specimens from Barrett's esophagus: a pilot feasibility study. (2004) (32)
- Cyclooxygenase‐2 in oligodendroglial neoplasms (2003) (32)
- BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma. (2014) (32)
- Malignant histiocytosis. Ultrastructural and immunocytochemical characterization. (1980) (31)
- Pseudo-gamma heavy chain (IgG4 lambda) deposition disease. (1992) (31)
- High MET Receptor Expression But Not Gene Amplification in ALK 2p23 Rearrangement Positive Non–Small-Cell Lung Cancer (2014) (31)
- Peripheral small cell undifferentiated carcinoma of the lung. Clinicopathologic features of 17 cases (1988) (31)
- Giant cell myocarditis. (1980) (31)
- Plasmacytoma of the ovary: a case report and literature review. (1999) (31)
- Use of similar immunoglobulin VH gene segments by MALT lymphomas of the ocular adnexa (2009) (31)
- Molecular pathology of breast cancer: the journey from traditional practice toward embracing the complexity of a molecular classification. (2011) (30)
- Telomerase activity in Stage II colorectal carcinoma (2002) (30)
- Biclonal chronic lymphocytic leukemia. (2000) (30)
- Use of novel t(11;14) and t(14;18) dual-fusion fluorescence in situ hybridization probes in the differential diagnosis of lymphomas of small lymphocytes. (2001) (30)
- Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction. (2013) (29)
- T cell lymphoma occurring in Sjögren's syndrome. (1984) (29)
- Atheroembolic renal disease: association with renal arterial stenosis. (1989) (29)
- The use of amplified variable number of tandem repeats (VNTR) in the detection of chimerism following bone marrow transplantation. A comparison with restriction fragment length polymorphism (RFLP) by Southern blotting. (1997) (29)
- Monosomy 3 by FISH in uveal melanoma: variability in techniques and results. (2012) (29)
- Chromosomal 3 and 8 status within hepatic metastasis of uveal melanoma. (2009) (28)
- Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effects. (1990) (28)
- Detection of MGMT promoter methylation in glioblastoma using pyrosequencing. (2015) (28)
- Fixation conditions for DNA and RNA in situ hybridization: a reassessment of molecular morphology dogma. (1998) (28)
- Improved sensitivity and resolution in the flow cytometric DNA analysis of human solid tumor specimens. Use of in vitro fine-needle aspiration and uniform staining reagents. (1991) (28)
- HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma (2013) (28)
- Automation of Manual Components and Image Quantification of Direct Dual Label Fluorescence In Situ Hybridization (FISH) for HER2 Gene Amplification: A Feasibility Study (2006) (27)
- Absence of B-cell or T-cell clonal expansion in nodular, lymphocyte predominant Hodgkin's disease. (1988) (27)
- The CD117 immunohistochemistry tissue microarray survey for quality assurance and interlaboratory comparison: a College of American Pathologists Cell Markers Committee Study. (2006) (27)
- Ultrasensitive RNA in situ hybridization for detection of restricted clonal expression of low-abundance immunoglobulin light chain mRNA in B-cell lymphoproliferative disorders. (2013) (27)
- Novel bright field molecular morphology methods for detection of HER2 gene amplification (2004) (27)
- A common copy-number breakpoint of ERBB2 amplification in breast cancer colocalizes with a complex block of segmental duplications (2012) (26)
- Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma. (2013) (26)
- Molecular Diagnostic Techniques for the Clinical Evaluation of Gliomas (2005) (26)
- Defective granzyme B gene expression and lytic response in T lymphocytes infiltrating human renal cell carcinoma. (1997) (26)
- Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three-color immunocytometry. (1991) (26)
- Nonsquamous neoplasms of the larynx. (1986) (26)
- Use of in situ hybridization to detect human papillomavirus in head and neck squamous cell carcinoma patients without a history of alcohol or tobacco use. (2008) (26)
- Quantitative Comparison of Immunohistochemical Staining Intensity in Tissues Fixed in Formalin and Histochoice (1997) (25)
- Interleukin 7 enhances the proliferation and effector function of tumor‐infiltrating lymphocytes from renal‐cell carcinoma (2009) (24)
- Molecular profiling of primary uveal melanomas with tumor-infiltrating lymphocytes (2019) (24)
- Fibrinolysis in familial pulmonary hypertension. (1979) (24)
- Angiotropic large-cell lymphoma in a patient with adrenal insufficiency. (1991) (24)
- Deoxyribonucleic acid ploidy and cell cycle analysis of colorectal carcinoma by flow cytometry. A prospective study of 137 cases using fresh whole cell suspensions. (1990) (24)
- Concomitant oncoprotein detection with fluorescence in situ hybridization (CODFISH): a fluorescence-based assay enabling simultaneous visualization of gene amplification and encoded protein expression. (2000) (24)
- Acute nonlymphocytic leukemia in patients receiving chemotherapy for nonmalignant diseases. (1980) (24)
- iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors (2015) (23)
- Fluorescence in situ hybridization analysis of immunoglobulin heavy chain translocations in plasma cell myeloma using intact paraffin sections and simultaneous CD138 immunofluorescence. (2006) (23)
- Interobserver Interpretative Reproducibility of GOLDFISH, A First Generation Gold-Facilitated Autometallographic Bright Field In Situ Hybridization Assay for HER-2/neu Amplification in Invasive Mammary Carcinoma (2002) (23)
- Langerhans Cell Histiocytosis (1998) (23)
- Antigenic phenotype of splenic hairy cells. (1984) (23)
- Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis. Case report. (1979) (23)
- Phase I trial of recombinant granulocyte-macrophage colony-stimulating factor in patients with lung cancer: clinical and immunologic effects. (1993) (22)
- Molecular regulation of intercellular adhesion molecule 1 (ICAM-1) expression in renal cell carcinoma (2004) (22)
- Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy. (2007) (21)
- Comparison of alternative chromogens for renal immunohistochemistry. (1981) (21)
- Immunotypic and genotypic characterization of non-Hodgkin's lymphomas of the ovary. (1988) (21)
- The Quality of Her-2/Neu Predictive Immunohistochemistry: Something FISHy? (2000) (21)
- Investigation of the clonality of lymphocytes in Hashimoto's thyroiditis using immunoglobulin and T-cell receptor gene probes. (1989) (21)
- Induction by interleukin-2 of oligoclonal expansion of cultured tumor-infiltrating lymphocytes. (1990) (21)
- Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders. (1998) (21)
- In Situ Hybridization Analysis of Lymphoproliferative Disorders: Assessment of Clonality by Immunoglobulin Light‐Chain Messenger RNA Expression (1994) (20)
- T lymphocyte proliferation in lymphomatoid granulomatosis. (1985) (20)
- In situ hybridization in the pathology laboratory: General principles, automation, and emerging research applications for tissue-based studies of gene expression (2004) (20)
- HER-2 amplification in tubular carcinoma of the breast. (2006) (20)
- Pulmonary lymphoid neoplasms. Role of immunohistology in the study of cellular immunotypes and in differential diagnosis. (1986) (20)
- Immunohistochemistry versus immunofluorescence for non-Hodgkin's lymphomas. (1980) (20)
- Detection of human papillomavirus in cervical carcinoma: comparison of peroxidase, Nanogold, and catalyzed reporter deposition (CARD)-Nanogold in situ hybridization. (1999) (20)
- The expression of CD22 (Leu 14) and CD11c (LeuM5) in chronic lymphoproliferative disorders using two-color flow cytometric analysis. (1991) (20)
- Activated T-cell subsets in benign lymphoid hyperplasias and B-cell non-Hodgkin's lymphomas. (1991) (19)
- Assessment of cellularity, genomic DNA yields, and technical platforms for BRAF mutational testing in thyroid fine‐needle aspirate samples (2014) (19)
- A data model to predict HER2 status in breast cancer based on the clinical and pathologic profiles of a large patient population at a single institution. (2006) (19)
- Expression profile and molecular genetic regulation of cyclin D1 expression in epithelioid sarcoma (2005) (19)
- Guidelines for HER2 testing in the UK (2004) (19)
- Concomitant Detection of HER2 Protein and Gene Alterations by Immunohistochemistry (IHC) and Silver Enhanced In Situ Hybridization (SISH) Identifies HER2 Positive Breast Cancer with and without Gene Amplification (2014) (18)
- The Utility of FOXO1 Fluorescence In Situ Hybridization (FISH) in Formalin-fixed Paraffin-embedded Specimens in the Diagnosis of Alveolar Rhabdomyosarcoma (2009) (18)
- Immunophenotypic and genotypic characterization of diffuse mixed non-Hodgkin's lymphomas. (1989) (18)
- Focal and segmental glomerulosclerosis. Immunohistologic study of 20 renal biopsy specimens. (1986) (18)
- Precursor Langerhans cell histiocytosis. An unusual histiocytic proliferation in a patient with persistent non-Hodgkin lymphoma and terminal acute monocytic leukemia. (1992) (17)
- Immunocytometry and gene rearrangement analysis in the diagnosis of lymphoma in an idiopathic pleural effusion. (1992) (17)
- Phase I trial of cisplatin, WR-2721, and the murine monoclonal antibody R24 in patients with metastatic melanoma: clinical and biologic effects. (1994) (17)
- Reliable and Cost‐Effective Paraffin Section Immunohistology of Lymphoproliferative Disorders (1991) (17)
- Genome‐wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features (2013) (17)
- T lymphocytes infiltrating renal cell carcinoma have a reduced expression of transferrin receptor (1994) (17)
- Immunoglobulin and T-cell receptor genes in thymomas: genotypic evidence supporting the nonneoplastic nature of the lymphocytic component. (1988) (17)
- Tumorigenicity in athymic mice of the human colon carcinoma cell line SW1116 expressing the tumor-associated antigenic determinant CA 19-9. (1984) (17)
- Phase Ia-Ib trial of an anti-GD3 monoclonal antibody in combination with interferon-alpha in patients with malignant melanoma. (1990) (16)
- Cytolytic (TIA-1+) tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas. SWOG Central Repository Members. (1993) (16)
- Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: evidence of impaired secretion in response to interleukin-12. (1999) (16)
- Immunoglobulin V genes in Reed-Sternberg cells. (1996) (16)
- Interlaboratory variability of immunohistochemical stains. Results of the cell markers survey of the College of American Pathologists. (1989) (16)
- De novo light-chain deposition disease in a cadaver renal allograft. (1996) (16)
- Immunoglobulin-gene rearrangement in benign lymphoepithelial lesions. (1987) (16)
- Immunoregulatory Leu-7+ and T8+ lymphocytes in B-cell follicular lymphomas. (1984) (16)
- IgM monoclonal gammopathy. Histopathologic and clinical spectrum. (1976) (16)
- Automated Brightfield Dual-Color In Situ Hybridization for Detection of Mouse Double Minute 2 Gene Amplification in Sarcomas (2011) (16)
- Molecular pathology testing of tissues fixed in prefer solution. (2004) (15)
- Complete remission of CD30-positive diffuse large B-cell lymphoma in a patient with post-transplant lymphoproliferative disorder and end-stage renal disease treated with single-agent brentuximab vedotin (2015) (15)
- Renal artery stenosis, nephrotic-range proteinuria, and focal and segmental glomerulosclerosis. (1984) (15)
- Antibodies against nuclear antigens: association with lupus nephritis. (1986) (15)
- Anti-glomerular and anti-tubular basement membrane nephritis in a renal allograft recipient with Alport's syndrome. (1994) (15)
- Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma. (1999) (15)
- Autoimmune and iatrogenic causes of lymphadenopathy. (1993) (15)
- Immunohistochemistry for BRAF V600E in the Differential Diagnosis of Hairy Cell Leukemia vs Other Splenic B-Cell Lymphomas. (2015) (15)
- Enzymatic Metallography: A Simple New Staining Method (2002) (15)
- Detection of clonal IGH gene rearrangements: summary of molecular oncology surveys of the College of American Pathologists. (2007) (15)
- Thrombotic thrombocytopenic purpura in a patient with AIDS. (1990) (15)
- Immunologic studies in two patients with persistent lymphocytic thyroiditis, thyrotoxicosis, and low radioactive iodine uptake. (1984) (15)
- The macrophagic origin of multinucleated giant cells in myeloma kidney: an immunohistologic study. (1987) (14)
- An immunoperoxidase technique to aid in the differential diagnosis of prostatic carcinoma. (1981) (14)
- Effect of oxygen on bleomycin-induced lung damage. (1987) (14)
- Fully automated dual‐color dual‐hapten silver in situ hybridization staining for MYC amplification: a diagnostic tool for discriminating secondary angiosarcoma (2014) (14)
- Choroidal metastases responsive to crizotinib therapy in a lung adenocarcinoma patient with ALK 2p23 fusion identified by ALK immunohistochemistry. (2013) (14)
- Phosphorus metabolites and the distribution of cell cycle phase of RIF‐1 tumors in response to 14 Gy irradiation (1990) (14)
- Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancer. (2009) (14)
- Expression of blood group antigen A by stage I non-small cell lung carcinomas. (1995) (14)
- Immunophenotypic spectrum of plasma cell leukemia (1989) (14)
- Calpain4 is required for activation of HER2 in breast cancer cells exposed to trastuzumab and its suppression decreases survival and enhances response (2012) (14)
- Enzyme immunohistochemistry: review of technical aspects and diagnostic applications. (1981) (14)
- Alternate chromogens as substitutes for benzidine for myeloperoxidase cytochemistry. (1981) (14)
- Uveal melanoma: prognostication. (2012) (13)
- Evaluation of chronic lymphocytic leukemia by oligonucleotide-based microarray analysis uncovers novel aberrations not detected by FISH or cytogenetic analysis (2011) (13)
- Renal cell carcinoma (RCC) and telomerase activity: relationship to stage. (2003) (13)
- JC Virus Chromogenic In Situ Hybridization in Brain Biopsies From Patients With and Without PML (2006) (13)
- In vivo Recombinant Adenovirus-mediated p53 Gene Therapy in a Syngeneic Rat Model for Colorectal Cancer (2004) (13)
- A simplified method of CD34+ cell determination for peripheral blood progenitor cell transplantation and correlation with clinical engraftment. (1998) (12)
- Supraclavicular lymphadenopathy due to silicone breast implants. (2007) (12)
- Immunoarchitectural patterns of germinal center antigens including LMO2 assist in the differential diagnosis of marginal zone lymphoma vs follicular lymphoma. (2013) (12)
- Immunomodulatory effects of interleukin-2 and interleukin-4 in patients with malignancy. (1996) (12)
- Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication. (2014) (12)
- An approach to the validation of novel molecular markers of breast cancer via TMA-based FISH scanning (2007) (12)
- Detection of bcl-2/J(H) translocation by polymerase chain reaction: a summary of the experience of the Molecular Oncology Survey of the College of American Pathologist. (2002) (12)
- Expression of monocytic--histiocytic cytochemical markers in epithelial neoplasia. (1979) (12)
- Diagnosis of BK viral nephropathy in the renal allograft biopsy: role of fluorescence in situ hybridization. (2012) (11)
- Demonstration of Immune Complex Deposits Using Fluorescence Microscopy of Hematoxylin and Eosin–Stained Sections of Hollande's Fixed Renal Biopsies (2002) (11)
- Downregulation of JAK 3 Protein Levels in T Lymphocytes by Prostaglandin E 2 and Other Cyclic Adenosine Monophosphate-Elevating Agents : Impact on Interleukin-2 Receptor Signaling Pathway (1999) (11)
- Molecular Genetic Testing of Polymorphisms Associated With Venous Thrombosis: A Review of Molecular Technologies (2005) (11)
- Chronic glomerular microangiopathy complicating metastatic carcinoma. (1987) (11)
- Detection of immunoglobulin light‐chain restriction in cutaneous B‐cell lymphomas by ultrasensitive bright‐field mRNA in situ hybridization (2015) (11)
- Immunophenotypic characterization of acute leukemia by immunocytology. (1984) (11)
- Array Comparative Genomic Hybridization in Ulcerative Colitis Neoplasia: Single Non-Dysplastic Biopsies Distinguish Progressors from Non-Progressors (2010) (11)
- Lymphocyte nuclear morphology in diffuse well-differentiated lymphocytic lymphoma. Comparative morphometry of normal lymphoid tissues, non-Hodgkin's lymphoma, and Hodgkin's disease. (1987) (11)
- Treatment of chronic lymphocytic leukemia with an anti-idiotypic monoclonal antibody. (1989) (10)
- Primary neuroendocrine differentiated mucinous adenocarcinoma of the vulva: case report and review of the literature. (1998) (10)
- Host tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas. (1993) (10)
- Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings. (1996) (10)
- Automation of immunohistology. (1989) (10)
- Modified Array-based Comparative Genomic Hybridization Detects Cryptic and Variant PML-RARA Rearrangements in Acute Promyelocytic Leukemia Lacking Classic Translocations (2013) (10)
- LightTyper™ platform for high-throughput clinical genotyping (2005) (10)
- Diffuse Large B-Cell Lymphoma of the Stomach: Assessment of Microsatellite Instability, Allelic Imbalance, and Trisomy of Chromosomes 3, 12, and 18 (2002) (9)
- Catalyzed Reporter Deposition: A New Era in Molecular and Immunomorphology-Nanogold-Silver Staining and Colorimetric Detection and Protocols. (1999) (9)
- An approach to immunomicroscopy of renal disease with immunoperoxidase and periodic acid-Schiff counterstain (IMPAS stain). (1980) (9)
- A double-blind comparative immunotypic study between two institutions phenotyping non-Hodgkin's lymphomas. (1987) (9)
- Interferon-g and CXC Chemokine Induction by Interleukin 12 in Renal Cell Carcinoma (1999) (9)
- Impaired activation of NFkappaB in T cells from a subset of renal cell carcinoma patients is mediated by inhibition of phosphorylation and degradation of the inhibitor, IkappaBalpha. (1998) (9)
- Correspondence re: Sano T, Hikino T, Niwa Y, Kashiwabara K, Oyama T, Fukuda T, Nakajima T. In situ hybridization with biotinylated tyramide amplification: detection of human papillomavirus DNA in cervical neoplastic lesions. Mod Pathol 1998;11:19-23. (1998) (8)
- Frequency, interobserver reproducibility and clinical significance of equivocal peaks in PCR clonality testing using Euroclonality/BIOMED-2 primers (2014) (8)
- Creation of a large-scale genetic data bank for cardiovascular association studies. (2005) (8)
- A comparative study of DNA quantitation in breast carcinoma with image cytometric analysis and in vitro fine-needle aspiration with flow cytometric analysis. (1993) (8)
- Extension of useful reagent shelf life beyond manufacturers' recommendations. Cell Markers Committee of the College of American Pathologists. (1998) (8)
- Lymphoproliferative disorders associated with carbamazepine. (1990) (8)
- The nature of surface immunoglobulin in pure monocytic (M5) leukemia. (1979) (8)
- Latent membrane protein 1, tumor necrosis factor receptor-associated factor (TRAF) 1, TRAF-2, TRAF-3, and nuclear factor kappa B expression in posttransplantation lymphoproliferative disorders. (2003) (8)
- Automated Bright-Field Dual-Color In Situ Hybridization for MDM2: Interobserver Reproducibility and Correlation With Fluorescence In Situ Hybridization in a Series of Soft Tissue Consults. (2016) (8)
- Wegener's granulomatosis. Immunomicroscopic and ultrastructural study of four cases. (1990) (8)
- Molecular morphology in human tissues : techniques and applications (2004) (8)
- Phase I clinical trial of interleukin 2 and alpha-interferon: toxicity and immunologic effects. (1989) (7)
- IgD myeloma. Report of a case with unusual clinical and immunologic features. (1979) (7)
- Cyclosporin-associated microfibrils in cardiac transplant patients. (1988) (7)
- Modulation of intestinal immune reactivity by interleukin 2 (1988) (7)
- Clinical Relevance of HPV 16/18 Testing Methods in Cervical Squamous Cell Carcinoma (2000) (7)
- Detection of MGMT promoter methylation in glioblastoma using pyrosequencing. (2015) (7)
- High-Resolution Immunophenotyping of Subcellular Compartments in Tissue Microarrays by Enzyme Metallography (2005) (7)
- From morphologic to molecular: established and emerging molecular diagnostics for breast carcinoma. (2012) (7)
- Interphase fluorescence in-situ hybridization in the diagnosis of bladder cancer. (2002) (7)
- Surgical Pathology of the Lymph Nodes and Related Organs (1995) (7)
- Phase I trial of continuous infusion interleukin-2 and doxorubicin in patients with refractory malignancies. (1991) (7)
- Elevated blood &bgr;-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma (2013) (7)
- Circulating cancer cells in renal-cell carcinoma. (1990) (7)
- Nephrotic range proteinuria with "minimal change glomerulopathy" in human renal allografts: report of four cases. (1988) (7)
- Large-cell lymphoma with diffuse sclerosis. A B-cell neoplasm of late-secretory, preplasma cells. (1986) (6)
- Histiocytosis X in a 27-year-old woman. (1983) (6)
- A case of large multilobated cell lymphoma. (1984) (6)
- A new rabbit monoclonal antibody (4B5) for the immuno-histochemical (IHC) determination of the HER2 status in breast cancer: comparison with CB11, fluorescence in situ hybridization (FISH), and interlaboratory reproducibility. (2008) (6)
- Cytoplasmic inclusions of Fabry's disease. Ultrastructural demonstration of their presence in urine sediment. (1981) (6)
- Surface and transmission ultrastructural characteristics of desquamative interstitial pneumonitis. (1978) (6)
- Chromogens for immunohistochemistry. (1981) (6)
- Upper airway obstruction due to tonsillar lymphadenopathy in human immunodeficiency virus infection. (1990) (6)
- Immunogold-silver staining for light microscopy using colloidal or clustered gold (Nanogold) (2002) (6)
- Utility of polymerase chain reaction in detecting B‐cell clonality in lymphoid neoplasms (1996) (6)
- The specificity of interphase FISH translocation probes in formalin fixed paraffin embedded tissue sections is readily assessed using automated staining and scoring of tissue microarrays constructed from murine xenografts (2007) (6)
- Comparative study of ELISA and indirect immunofluorescence for the detection of anti-neutrophil cytoplasmic antibodies. Evaluation of the SCIMEDX/EURO Diagnostica ELISA assay in a clinical setting. (1995) (6)
- Frozen sections of cellular lymphoid proliferations provide adequate DNA for routine gene rearrangement analysis. (1991) (6)
- MET and PTEN gene copy numbers and Ki-67 protein expression associate with pathologic complete response in ERBB2-positive breast carcinoma patients treated with neoadjuvant trastuzumab-based therapy (2016) (5)
- Acquired factor X deficiency in systemic amyloidosis. (1987) (5)
- 3 - Tissue Microarrays and Their Modifications in High-Throughput Analysis of Clinical Specimens (2002) (5)
- Combination therapy with a synthetic peptide of C-reactive protein and interleukin 2: augmented survival and eradication of pulmonary metastases (2005) (5)
- Primary ultrastructural diagnosis of cryoglobulinemic glomerulonephritis. (1981) (5)
- Immunocytochemical identification of human chorionic gonadotropin. Comparative study of diaminobenzidine and 3-amino, 9-ethylcarbazole, a nonhazardous chromogen. (1979) (4)
- Reliability of immunofluorescence of renal tissue obtained at autopsy. (1979) (4)
- Is hemisplenectomy a satisfactory option to total splenectomy in abdominal staging of Hodgkin's disease? (1987) (4)
- Number of Lymphoma-Associated-Macrophages (LAM) Is An Independent Predictor of Survival in Patients with Mantle Cell Lymphoma (MCL) (2009) (4)
- Cross reactive immunologic staining: was it really prostatic carcinoma? (1982) (4)
- Relative merits of the avidin-biotin complex (ABC) and unlabeled peroxidase-antiperoxidase technics for studying polypeptide hormones. (1982) (4)
- Tissue reactivity of anti‐Leu19 (1992) (4)
- From array to array: Confirmation of genomic gains and losses discovered by array-based comparative genomic hybridization utilizing fluorescence in situ hybridization on tissue microarrays (2007) (4)
- Kaposi's sarcoma, angioimmunoblastic lymphadenopathy, and antibody to HIV-1 p24 antigen in a patient nonreactive for HIV-1 with use of ELISA. (1990) (4)
- Retraction: Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant (2012) (3)
- Genotyping of phenotypically defined cells in neoplasia: enhanced immunoFISH via tyramide signal amplification (TSA) segregates immunophenotypically—defined cell populations for gated genotyping (2007) (3)
- Gefitinib in definitive management of esophageal or gastroesophageal junction cancer: a retrospective analysis of two clinical trials. (2015) (3)
- Successful renal transplantation in a patient with large granular lymphocytic leukemia with natural killer cell proliferation. (1996) (3)
- Memory T cell subsets in B cell non-Hodgkin's lymphomas. (1996) (3)
- 267: Prospective Analysis of Urine Cytology Ancillary Multitarget Fluorescence In-Situ Hybridization Assay in the Detection of Recurrent Transitional Cell Carcinoma in Patients with Atypical and Negative Cytology (2004) (3)
- Chromogens for immunohistochemistry. (1981) (3)
- Review Article Flow Cytometric Immunophenotyping of Non-Hodgkin's Lymphomas and Related Disorders (1996) (3)
- Occurrence of ribosome-lamella complexes. (1983) (3)
- The use of isotypic control antibodies in the analysis of CD3+ and CD3+, CD4+ lymphocyte subsets by flow cytometry. Are they really necessary? (1997) (3)
- Lymphoma of prosthetic aortic graft presenting as recurrent embolization. (2015) (3)
- Two Unusual Cases of the Posterior Cranial Fossa Blood Supply (2014) (3)
- Silver-enhanced In Situ Hybridization for Detection of Polyomavirus DNA in Patients With BK Virus Nephropathy (2011) (3)
- HER2 amplification does not alter outcome in small (≤1 cm) tumors. (2009) (2)
- Analyte-specific reagents and the clinical laboratory. (1998) (2)
- Responses to T cell receptor/CD3 and interleukin-2 receptor stimulation are altered in T cells from B cell non-hodgkin's lymphomas (1995) (2)
- MYC Protein Expression, but Not High Grade Morphology, Is Associated with Poor Outcome in Non-Burkitt Diffuse Aggressive B-Cell Lymphomas: A SWOG S9704 Correlative Study (2012) (2)
- Clinicopathologic features and treatment outcomes of patients (pts) with HER2-positive (pos) adenocarcinomas (ACA) of the esophagus (E) and gastroesophageal junction (GEJ). (2011) (2)
- Insuring effective antimicrobial therapy: laboratory evaluation. (1977) (2)
- ALK-immunohistochemistry (IHC) standardization with D5F3 antibody in non-small cell lung carcinoma (NSCLC): An international consensus study. (2013) (2)
- The Percentage of Cytotoxic T-Cells in Mantle Cell Lymphoma (MCL) Biopsies Predicts Response to Rituximab. (2009) (2)
- Macroglobulinemia and malabsorption. (1977) (2)
- Paracortical immunoregulatory subpopulations in lymph nodes from homosexual men with persistent generalized lymphadenopathy. (1988) (2)
- Determination of T cell monoclonality in non-Hodgkin's lymphoma by frozen section immunohistology. The SWOG Central Repository Members. (1992) (2)
- Muramidase, an immunohistochemical marker of malignant histiocytosis. (1979) (2)
- Desquamative Interstitial Pneumonitis vs Usual Interstitial Pneumonitis (1978) (2)
- Bilateral solid renal masses in a young man. (1986) (2)
- Gold nephropathy. (1977) (2)
- Fluorescence in situ hybridization (FISH) of endoscopic brush cytology from barrett's esophagus detects genetic changes in high-grade dysplasia and adenocarcinoma not seen in patients without dysplasia (2003) (2)
- Molecular Genetic Characterization of Primary Cutaneous B-Cell Lymphomas (2001) (2)
- Ultrastructural and immunomorphologic study of perinuclear filaments in Merkel cell tumors. (1985) (2)
- Detection of bcl-2/JH Translocation by Polymerase Chain Reaction (2009) (2)
- Guest Reviewer (2000) (2)
- The influence of immunology and genetics on lymphoma classification: a historical perspective. (1996) (2)
- Gold- and Silver-Facilitated Metallographic In Situ Hybridization Procedures for Detection of HER2 Gene Amplification (2004) (2)
- Confirming myeloid differentiation. (1983) (2)
- Clinicopathologic features and treatment outcomes of patients (pts) with HER2-positive (pos) adenocarcinomas (ACA) of the esophagus (E) and gastroesophageal junction (GEJ). (2011) (2)
- Phase IA/IB Trial of rhIL-6 in Patients with Refractory Malignancies: An Immunomodulatory Cytokine (1993) (2)
- Surface ultrastructure of giardial infestation. (1976) (2)
- MUM1 Expression in Follicular Lymphoma Is a Poor Prognostic Marker in Patients Treated with Immunochemotherapy (SWOG 9800/9911) but Not Chemotherapy Alone (SWOG 8809): A Southwest Oncology Group Correlative Science Study (2008) (2)
- The 76-Gene Signature Defines High-Risk Patients That Benefit from Adjuvant Tamoxifen Therapy. (2009) (2)
- Gender differences and estrogen and progesterone receptor expression in uveal melanoma (2013) (2)
- Biological Significance of Prostatic Carcinoma after Definative Radiation Therapy (1987) (2)
- Mutations in Myeloid Neoplasms (2008) (2)
- Concurrent BCL2 and MYC Protein Expression by Immunohistochemistry Determines Clinical Outcome In DLBCL Patients Treated with R-CHOP (2010) (1)
- CD30 expression in non-small cell lung cancer with and without ALK gene rearrangement. (2014) (1)
- Validation of genomic markers that predict distant recurrence risk via FISH assays in women with early stage breast carcinoma (2007) (1)
- Prostate metabolism of steroids following castration. (1987) (1)
- Immunohistochemistry of Lymphomas in Frozen Tissue Sections (1985) (1)
- In vitro activation of lymphocytes by interleukin 2 in patients with renal cell carcinoma. (1989) (1)
- Improved Detection of Monosomy 3 in Uveal Melanoma Using Double-Target FISH with Centromeric and 3p25 Probes (2011) (1)
- using gene expression in formalin-fixed paraffin-embedded tissue Determining cell-of-origin subtypes of diffuse large B-cell lymphoma (2014) (1)
- Comprar Cell and Tissue Based Molecular Pathology | Raymond R. Tubbs | 9780443069017 | Churchill Livingstone (2008) (1)
- Use of HER2 score correction for putative chromosome 17 (Chr-17) aneusomy to increase eligibility for anti-HER2 therapy. (2012) (1)
- The sensitivity and specificity of monoclonal antibodies URO-2 and 19-9 in the immunohistochemical classification of primary adenocarcinomas. (1986) (1)
- Impaired Signal Transduction in Tumor Infiltrating T Cells from Patients with Renal Cell Carcinoma (1995) (1)
- Diagnostic utility of morphologic criteria encountered in malignant lymphoid cells. (1981) (1)
- Effect of kinesins on taxane resistance. (2010) (1)
- Scientific category : LYMPHOID NEOPLASIA Title : A new biological prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma (2012) (1)
- Novel Methodology for Detection of EGFR Gene Mutation and ALK Gene Rearrangement From FNA-Based Sampling in Non-small Cell Lung Cancer: Potential Implications on EBUS-TBNA (2013) (1)
- Immunohistochemistry for BRAF V 600 E in the Differential Diagnosis of Hairy Cell Leukemia vs Other Splenic B-Cell Lymphomas (2015) (1)
- High false-negative rate of HER2 qRT-PCR of the Oncotype DX test: An independent quality assurance study. (2011) (1)
- p53 expression in intraductal epithelial hyperplasia, atypical intraductal hyperplasia, and intraductal carcinoma of the breast. (1996) (1)
- Toluidine blue and methylene blue stains in nephropathy of Fabry's disease (1980) (1)
- Molecular Signatures Implicate Innate Immune Cells, Fibrosis, and Angiogenesis in Survival Following R-CHOP Treatment of Diffuse Large B Cell Lymphoma (2008) (1)
- An elderly black woman with a painful, "swollen" face. (1985) (1)
- Case report. Irreversible chronic renal failure following jejunoileal bypass. (1980) (1)
- Leukemia occurring in treated Hodgkin's disease: two neoplasms or one? (1979) (1)
- Loss of vasoactive intestinal polypeptide immunoreactive nerve fibres in the colon of IBD patients (1990) (1)
- High Throughput Morphological Gene Expression Studies Using Automated mRNA In Situ Hybridization Applications and Tissue Microarrays for Post-Genomic and Clinical Research (2004) (1)
- Determining Cell-Of-Origin Subtypes In Diffuse Large B-Cell Lymphoma Using Gene Expression Profiling On Formalin-Fixed Paraffin-Embedded Tissue – An L.L.M.P.P. Project (2013) (1)
- Clinical correlates of HER2 amplification: A multivariable analysis (2005) (1)
- Abstract P1-02-04: Array based resolution of HER2 amplification status in breast carcinomas displaying apparent chromosome 17 aneusomy (2013) (1)
- Tyramide Amplification Methods for In Situ Hybridization (2001) (1)
- In Vivo Determination Of Bone Density--A Comparative Study (1976) (1)
- Expression of cell adhesion molecules in an established and characterized new human renal cell cancer line, CCF-RC7 (2004) (1)
- Clinicopathologic conference: fever of unknown origin in a 70-year-old woman. (1976) (1)
- Accurate Classification of Diffuse Large B Cell Lymphoma Into Germinal Center and Activated B Cell Subtypes Using a Nuclease Protection Assay On Formalin Fixed Paraffin Embedded Tissue: A Study From the Lymphoma and Leukemia Molecular Profiling Project. (2009) (0)
- An approach to preliminary studies of interlaboratory comparative results for estrogen and progesterone receptors. (1994) (0)
- Ki 67 estrogen receptors by dcc and er ica and histologic grading in carcinoma of the breast (1988) (0)
- The Efficacy of In Situ PCR, CARD and Nanogold Systems for Gene Detection (1997) (0)
- Absolute neutrophil count (ANC) pattern with accelerated dose-intensified epirubicin chemotherapy and pegfilgrastim support. (2004) (0)
- Molecular genetic characterization of primary cutaneous B-cell lymphomas. Authors' reply (2001) (0)
- Clinical implications of routine testing for epidermal growth factor receptor (EGFR) mutations in patients with nonsquamous non-small cell lung cancer (NSCLC). (2013) (0)
- T cell (CD3+) chimerism after non-myeloablative allogeneic hematopoietic stem cell transplantation (NMHSCT) (2004) (0)
- Abstract P6-07-45: Molecular Morphology Based Genomic Signatures of Moderate Complexity Predict Pathologic Complete Response inHER2Molecular Breast Carcinoma Class Patients Treated with Trastuzumab-based Preoperative Therapy. (2012) (0)
- A Novel use of Fluorescence Microscopy in Evaluation of Renal Biopsies (1997) (0)
- Lymphoproliferative disorders. (1987) (0)
- Suppression of tcr-cd3 linked tyrosine phosphorylation of normal peripheral blood T cells by tumor supernatants from renal cell carcinoma (RCC) (1996) (0)
- Paraffin-Embedded Tissues Nuclease Protection Assay on Formalin-Fixed , into Germinal Center and Activated B-Cell Subtypes Using a Accurate Classification of Diffuse Large B-Cell Lymphoma (2011) (0)
- Numbers of Lymphoma Associated Macrophages (LAMS) and Regulatory T-Cells (Tregs) in Follicular Lymphoma (FL) Patients (pts) Treated with and without Monoclonal Antibody (MoAb)-Containing Therapy Do Not Correlate with Overall Survival (OS): A Study from the Southwest Oncology Group (SWOG). (2007) (0)
- P4-09-22: Multicenter Quality Assurance Profile Review of Lobular Breast Carcinomas Versus the 21 Gene Recurrence Score: Assessment of Clinical Relevance. (2011) (0)
- Comprar Comprehensive resource on the Chiari malformations | W. Jerry Oakes | 9781461463689 | Springer (2014) (0)
- In Situ Techniques: Visualizing the Genome and Its Expression (2014) (0)
- Array-Based Comparative Genomic Hybridization as a Tool for Survey of Genomic Alterations in Human Neoplasms (2004) (0)
- 3P FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR DETECTION OF ALK REARRANGEMENTS VIA THINPREP CYTOLOGY PREPARATIONS IN NON SMALL CELL LUNG CARCINOMA (NSCLC) (2013) (0)
- Large-cell lymphoma with diffuse sclerosis (2013) (0)
- Squamous Cell Carcinoma of the Nailbed: a Histopathologic Study of 12 Cases (1990) (0)
- Histopathologic diagnosis of granulocytic sarcoma. (1990) (0)
- Using novel protein antibodies on tissue microarrays (TMAs) for breast cancer prognostication. (2004) (0)
- Correlation of Genetic Polymorphisms Detected by Geneohm EPLEX™ Electrochemical Platform with Functional Study for Venous Thrombosis. (2004) (0)
- Immunoperoxidase Staining For c-MET In Uveal Melanoma And Metastases (2011) (0)
- P1-07-05: HER2 Status Resolution in FISH and IHC “Double Equivocal” Breast Carcinomas by Quantitative Real-Time PCR. (2011) (0)
- Super-Sensitive In Situ Hybridization: Tyramide Signal Amplification and Nanogold-Gold Staining (1999) (0)
- Atlas of immunohistology by Raymond R. Tubb, Gordon N. Gephardt and Robert E. Petras, American Society of Clinical Pathologists Press, 1986. $109 (xviii + 197 pages) ISBN 0 89189 205 2. (1987) (0)
- Primary Cutaneous Ewing’s Sarcoma/Primitive Neuroectodermal Tumor Mimicking Malignant Eccrine Spiradenoma with 22q12 Translocation by Interphase Fluorescent in Situ Hybridization (2008) (0)
- Assessment of Cellularity and Genomic DNA Yields from Thyroid FNA Samples (2012) (0)
- Cytokine Therapy of Metastatic Renal Cell Carcinoma: The Cleveland Clinic Experience (1995) (0)
- Aspiration biopsy of the lung. (1976) (0)
- An international study to standardize the detection of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR (2003) (0)
- Tyramide signal-amplified gold-silver and gold-gold in situ hybridisation: single copy sensitivity for virus detection (2001) (0)
- IL-2 Based Combination Therapy of Malignant Disease: Summary of the Phase I Experience at the Cleveland Clinic (1992) (0)
- MET and PTEN gene copy numbers and Ki-67 protein expression associate with pathologic complete response in ERBB2-positive breast carcinoma patients treated with neoadjuvant trastuzumab-based therapy (2016) (0)
- Posterior Midvenricsular Rupture after Mitral Valve Replacement (1978) (0)
- PP45 Analytical performance of a novel dual color dual hapten brightfield genotypic assay for determination of HER2 status in breast carcinoma (DDISH) (2009) (0)
- Genome-wide miRNAprofiling of mantle cell lymphoma reveals a distinctsubgroup with poor prognosis (2019) (0)
- Comparison of peroxidase-, Nanogold- and CARD-Nanogold in situ hybridication for the detection of human papillomavirus in cervical carcinoma (1999) (0)
- Escape of EML4-ALK NSCLC to early phase precision therapy through TGFβ2-HOX-bioenergetics reprogramming. (2014) (0)
- Use of a novel in situ hybridization technique to detect human papillomavirus in head and neck squamous cell carcinoma patients without a history of alcohol or tobacco use (2007) (0)
- A retrospective analysis of the role of gefitinib in the definitive management of esophageal/gastroesophageal junction (E/GEJ) cancer. (2013) (0)
- WS3-5 Out of the dark and into the light : a bright field alternative to fluorescence in situ hybridization for detection of HER-2/neu gem amplification (2002) (0)
- Acquired factor X amyloidosis 1 deficiency in systemic (2013) (0)
- Case report Macroglobulinemia and malabsorption (2013) (0)
- Immunohistochemical Evaluation Of the H3k9Trime repressive mark In Uveal Melanomas With Correlation To H3K4Me3, Monosomy 3 And Clinical Outcome (2012) (0)
- PP44 Development of a quantitative scoring algorithm for a Dual-Hapten, Dual-Color ISH assay (DDISH) to determine HER2 gene status (2009) (0)
- Detection of Human T-Cell Lymphotropic Virus Type 1 Proviral Sequences from Tissue Samples of Patients with malignant T-Cell Lymphoma (1995) (0)
- Cutaneous T-cell immunoblastic sarcoma. (1983) (0)
- subgroups in peripheral T-cell lymphoma Gene expression signatures delineate biological and prognostic (2014) (0)
- Abstract PD02-04: Automated Quantitative RNA In Situ Hybridization for Resolution of Equivocal and Heterogeneous ERBB2 (HER2) Status in Invasive Breast Carcinoma (2012) (0)
- Highly sensitive in situ hybridization technique: tyramide signal amplification (TSA TM) or catalyzed reporter deposition (CARD) (1999) (0)
- Gold nephropathy. (1979) (0)
- Peripheral blood progenitor cell mobilization: vp-16 + g-csf generates fewer cd34+ cd33- cells than g-csf alone (2000) (0)
- IgM Monoclonal Gammopathy (2020) (0)
- ‘ ‘ focus on . . . ’ ’ session : profiling and prognosis (2008) (0)
- HER2 amplification predicts breast cancer recurrence but not overall survival. (2009) (0)
- Cyclin D1 Immunohistochemistry Identifies a Subset of Plasma Cell Myeloma with Superior Overall Survival. (2004) (0)
- Primary cutaneous B-cell lymphoma Report of a case and review of the English-language literature 1 Dermatology Feature (2013) (0)
- Using novel protein antibodies on tissue microarrays (TMAs) for breast cancer prognostication (2004) (0)
- Microdeletions at Apparently Balanced Translocation Breakpoints Are Biomarkers for Heightened Genomic Instability in Patients with Non-MLL Acute Myeloid Leukemia (2011) (0)
- Clinical characteristics of NSCLC harboring ALK 2p23 translocation at Cleveland Clinic. (2012) (0)
- CLINICAL PATHOLOGIC REVIEWS (2008) (0)
- Microarray Analysis of Formalin-Fixed Paraffin-Embedded (FFPET) and Frozen (FZT) Uveal Melanoma Detects Clinically Relevant Abnormalities, Including Chromosome 3 Loss of Heterozygosity (2013) (0)
- Detection of Copy Number Alterations in DNA Repair/Repair-Related Genes for a Diversity of Hematologic Malignancies Identifies Disease-Specific Biomarkers of Potential Clinical Relevance. (2012) (0)
- Tumoral MET/HGF expression and MET gene amplification in patients with ALK 2p23 fusion driven lung cancer. (2013) (0)
- Clinical Results and Characterization of Tumor-infiltrating Lymphocytes with or without Recombinant Interleukin 2 in Human Metastatic Renal Cell Carcinoma 1 (2006) (0)
- Immunologic studies of peripheral blood lymphocytes and lymph nodes in Hodgkin's disease. A preliminary report. (1985) (0)
- High Microvascular Density Correlates with Poor Outcome in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab Plus Chemotherapy (R-CT). (2009) (0)
- Pulmonary immunohistology. (1985) (0)
- Abstract 3117: Complex genomic regions associated with ERBB2 amplification in breast cancer (2012) (0)
- Challenges of DNA and RNA detection: catalyzed reproter deposition - a new era in molecular and immunomorphology - nanogold-silver staining and colorimetric detection and protocols (1998) (0)
- New guideline sets the ground rules for routine molecular testing in non-small cell lung cancer. (2013) (0)
- Cellular Phase of Fibrosing Alveolitis (2017) (0)
- 20P Qrt-Pcr Based Determination of Her2 Status of Invasive Breast Carcinomas Equivocal by Both Immunohistochemistry (Ihc) and Fluorescence in Situ Hybridization (Fish) Testing (2012) (0)
- Expression of Ia determinants on mouse L3T4 (CD4 sup + ) immune cells that mediate contact sensitivity to the hapten trinitrochlorobenzene (1991) (0)
- Tissue Microarrays: Robust Molecular Morphology Tools (2007) (0)
- Specific chemokine expression in vivo correlates with highly selective leukocytic infiltration (1994) (0)
- Ocular and Adnexal Benign Reactive Lymphoid Hyperplasia (2014) (0)
- Effects of interleukin-12 on interferon-gamma production by peripheral blood and tumor infiltrating T-lymphocytes from renal cell carcinoma patients: Evidence of impaired secretion (1996) (0)
- Abstract P6-08-46: Clinical outcomes of breast cancer patients with intermediate oncotype DX recurrence scores (RS): A review of the Cleveland Clinic Experience (2015) (0)
- Abstract 2374: Tumoral MET expression and plasma HGF level in patients with ALK 2p23 fusion driven lung cancer. (2013) (0)
- A commentary on laboratory practices in the reporting of flow cytometry phenotyping results for leukemia/lymphoma specimens: Results of a survey (1995) (0)
- Reply to A.M. Gown et al and F.L. Baehner et al (2012) (0)
- HER2 status in bilateral breast cancer. (2006) (0)
- Suppression of nficb activation in normal T cells by soluble products from renal cell carcinoma explants (1996) (0)
- Establishment of Two New Renal Cell Carcinoma Lines: Biological Difference of CRT is from the Erimary Tumor vs Those of Renal Vein Effluent (1987) (0)
- Lymphoma Immunotyping: A Practical Approach (1986) (0)
- Combination Therapy of Renal Cell Carcinoma with Interleukin-2 and Interferon Alpha: The Cleveland Clinic Experience (1991) (0)
- Anatomic Pathology / Histologic Spectrum of Myxoid Liposarcoma (2012) (0)
- Role of Immunohistology in the Study of Cellular Immunotypes and in Differential Diagnosis (2017) (0)
- Recent developments in in situ hybridization, with special emphasis on NanogoldTM and catalyzed reporter deposition (CARD; Tyramide Signal AmplificationTM ) (1999) (0)
- Application of tyramide signal amplification and Nanogold autometallography in in situ hybridization detection of human papillomavirus in cervical carcinoma (2000) (0)
- MYC Translocations and Expression Are Clinically Important in R-CHOP Treated Patients with De Novo DLBCL. (2009) (0)
- University of Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics (2012) (0)
- In vivo Determination of Bone Density -A Comparative Study (1977) (0)
- Toward Molecular Sensitivity: Tyramide Signal Amplification in Molecular Morphology (2004) (0)
- Necessary for IL-12-Mediated Regression of the The CXC Chemokines IP-10 and Mig Are (2013) (0)
- An Immunohistochemical Method for Large Scale Specificity Screening of Monoclonal Antibodies (1983) (0)
- In situ hybridisation with tyramide signal-amplification (TSA TM) in combination with various fluorochromes and chromogens (2000) (0)
- Prognostic FNAB of Uveal Melanoma (2013) (0)
- Primary cutaneous B-cell lymphoma. Report of a case and review of the English-language literature. (1985) (0)
- Autotaxin Expression in Cytologic Preparations of Uveal Melanoma (2010) (0)
- Development of Amplifi cation‐Based Molecular Genetic Testing in Hematology (2012) (0)
- An Open Door to Molecular Cytopathology: Interphase Fluorescence In Situ Hybridization (FISH) on Liquid-Based Thin-Layer Preparations (2004) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Raymond R. Tubbs?
Raymond R. Tubbs is affiliated with the following schools:
